Bergh; Niklas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bergh; Niklas.The latest application filed is for "compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors".

Company Profile

4.3.9

Bergh; Niklas - Askim SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation Grant 11,400,064 - Jern , et al. August 2, 2	2022-08-02
Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof Grant 11,395,808 - Gustafsson , et al. July 26, 2	2022-07-26
Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors App 20210060014 - Larsson; Pia ; et al.	2021-03-04
Compounds And Compositions For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition A App 20200179381 - Bergh; Niklas ; et al.	2020-06-11
Delayed Release Pharmaceutical Formulations Comprising Valproic Acid, And Uses Thereof App 20190111011 - Gustafsson; Nils Ove ; et al.	2019-04-18
Valproic Acid For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition And/or Thrombus Formation App 20190015360 - Jern; Sverker ; et al.	2019-01-17
Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation Grant 10,111,845 - Jern , et al. October 30, 2	2018-10-30
Valproic Acid For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition And/or Thrombus Formation App 20180177751 - Jern; Sverker ; et al.	2018-06-28
Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors App 20170020874 - Larsson; Pia ; et al.	2017-01-26
Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors App 20140051716 - Larsson; Pia ; et al.	2014-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.